Catalyst Wire Dossier Catalyst Wire Dossier

Decitabine (oral)

decitabine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Decitabine (oral), covering 2026-04-02 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Oral Decitabine Plus Ivosidenib as First Line for Older/Unfit Adult AML Patients [Phase 2]

See pricing